Castle Biosciences (CSTL)

• Market cap: $564M
• 1 day: -1.20%
• 5 days: -5.00%
• 1 month: -7.01%
• 3 months: -29.46%
• 6 months: -29.58%
• Year to date: -29.46%
• 1 year: -11.10%
• 5 years: -31.25%
• 10 years: -7.57%
• Sector: Healthcare
• Industry: Medical Laboratories

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

272% more call options, than puts

Call options by funds: $3.7M | Put options by funds: $996K

44% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 27

5% more funds holding

Funds holding: 184 [Q3] → 194 (+10) [Q4]

1.23% more ownership

Funds ownership: 93.08% [Q3] → 94.31% (+1.23%) [Q4]

3% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 64

4% less capital invested

Capital invested by funds: $737M [Q3] → $704M (-$32.8M) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 4 [Q3] → 2 (-2) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $37 87% upside
• Avg. target: $39 97% upside
• High target: $41 107% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Baird Catherine Ramsey 31% 1-year accuracy 5 / 16 met price target	87% upside $37	Outperform Maintained	28 Feb 2025
Stephens & Co. Mason Carrico 18% 1-year accuracy 5 / 28 met price target	107% upside $41	Overweight Reiterated	2 Jan 2025